The overlap of primary Sjögren's syndrome with antiphospholipid syndrome in man: Case report;Zespół Sjögrena skojarzony z zespołem antyfosfolipidowym u mȩżczyzny - Trudności diagnostyczne: Opis przypadku

Polskie Archiwum Medycyny Wewnetrznej

Volumn 117, Issue SUPPL., 2007, Pages 76-78

  Wielosz, Ewa ^a   Majdan, Maria ^a   Koszarny, Arkadiusz ^a   Zychowska, Iwona ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antiphospholipid syndrome; Primary Sj gren syndrome

Indexed keywords

ACENOCOUMAROL; CHLOROQUINE; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; MALE; SJOEGREN SYNDROME;

EID: 36549039524     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61: 554-558.
2. Ramos-Casals M, Brito-Zeron P, Font J. The overlap of Sjögren's Syndrome with other systemic autoimmune diseases. Semin Arthritis Rheum. 2006; 28: 246-255.
3. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4: 295-306.
4. Fauchais A, Lambert M, Launay D, et al. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in series of 74 patients. Lupus. 2004; 13: 245-248.
5. Ramos-Casals M, Nardi N, Brito-Zeron P, et al. Atypical autoantibodies in patients with primary Sjögren Syndrome: Clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum. 2006; 35: 312-321.
6. Ruiz-Irastorza G, Egurbide MV, Ugalde J, et al. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med. 2004; 164: 77-82.
7. Perez-Vazquez ME, Villa AR, Drenkard C, et al. Influence of disease duration, continued follow up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. J Rheumatol. 1993; 20: 437-442.
8. Dafni UG, Tzioufas AG, Staikos P, et al. Prevalence of Sjögren's Syndrome in a closed rural community. Ann Rheum Dis. 1997; 56: 251-255.
9. Halse ATP, Wahren-Herlenius M, Haga H, et al. Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjögren's syndrome. Scand J Immunol. 1999; 49: 533-538.
10. Lambert M, Launay D, Fauchais AL, et al. Anticardiolipin antibodies IgG associated to an hypergammaglobulinemia are not thrombotic markers: about 294 patients. J Autoimmun. 2000; 15: A55.